|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development expenses | |||||
| Selling, general and administrative expenses | |||||
| Change in fair value of contingent consideration (Note 2) | |||||
| Intangible asset impairment (Note 4) | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Interest income | |||||
| Loss on debt extinguishment | |||||
| Other income (expense) | |||||
| Loss before income tax expense | |||||
| Income tax expense | |||||
| Net loss | |||||
| Comprehensive loss, net of tax | |||||
| Net loss per share: | |||||
| Basic net loss per share (in usd per share) | |||||
| Diluted net loss per share (in usd per share) | |||||
| Weighted average shares outstanding: | |||||
| Weighted average shares outstanding, basic (in shares) | |||||
| Weighted average shares outstanding, diluted (in shares) | |||||
| Comprehensive income (loss): | |||||
| Unrealized gain on investments | |||||
| Foreign currency translation adjustment | |||||
| Other comprehensive income (loss) |
Loading...